SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $12,536,000 | -76.1% | 436,477 | +16.8% | 1.03% | -33.5% |
| Q3 2019 | $52,444,000 | +94.3% | 373,828 | +120.3% | 1.55% | +159.9% |
| Q1 2019 | $26,987,000 | -44.3% | 169,676 | -66.5% | 0.60% | -53.7% |
| Q4 2018 | $48,448,000 | +807.1% | 505,776 | +573.0% | 1.29% | +860.4% |
| Q1 2017 | $5,341,000 | -15.9% | 75,158 | -62.1% | 0.13% | -31.6% |
| Q1 2016 | $6,350,000 | +166.6% | 198,058 | +384.8% | 0.20% | +172.2% |
| Q4 2015 | $2,382,000 | – | 40,850 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |